{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:48:08Z","timestamp":1791042488509,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"5-6","license":[{"start":{"date-parts":[[2005,6,11]],"date-time":"2005-06-11T00:00:00Z","timestamp":1118448000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1007\/s00228-005-0950-5","type":"journal-article","created":{"date-parts":[[2005,6,10]],"date-time":"2005-06-10T11:41:56Z","timestamp":1118403716000},"page":"395-398","source":"Crossref","is-referenced-by-count":20,"title":["Thiopurine S-methyltransferase as a target for drug interactions"],"prefix":"10.1007","volume":"61","author":[{"given":"Hua-Wen","family":"Xin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Klotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,6,11]]},"reference":[{"key":"950_CR1","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMra020831","volume":"347","author":"DK Podolsky","year":"2002","unstructured":"Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347:417\u2013429","journal-title":"N Engl J Med"},{"key":"950_CR2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/gut.51.2.143","volume":"51","author":"L Lennard","year":"2002","unstructured":"Lennard L (2002) TPMT in the treatment of Crohn\u2019s disease with azathioprine. Gut 51:143\u2013146","journal-title":"Gut"},{"key":"950_CR3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","volume":"14","author":"E Schaeffeler","year":"2004","unstructured":"Schaeffeler E, Fischer C, Brockmeier D, Wernet D, Moerike K, Eichelbaum M, Zanger U, Schwab M (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants. Pharmacogenetics 14:407\u2013417","journal-title":"Pharmacogenetics"},{"key":"950_CR4","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S1542-3565(04)00343-X","volume":"2","author":"LJ Egan","year":"2004","unstructured":"Egan LJ (2004) Drug interactions in gastroenterology: mechanisms, consequences, and how to avoid. Clin Gastroenterol Heptol 2:725\u2013730","journal-title":"Clin Gastroenterol Heptol"},{"key":"950_CR5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1365-2125.1995.tb04478.x","volume":"39","author":"CL Szumlanski","year":"1995","unstructured":"Szumlanski CL, Weinshilboum RM (1995) Sulphasalazine inhibition of thiopurine methyltransferase: possible mechanism for interaction with 6-mercaptopurine and azathioprine. Br J Clin Pharmacol 39:456\u2013459","journal-title":"Br J Clin Pharmacol"},{"key":"950_CR6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1365-2036.2005.02460.x","volume":"21","author":"Xin","year":"2005","unstructured":"Xin HW, Fischer C, Schwab M, Klotz U (2005) Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease. Aliment Pharmacol Ther 21:1105\u20131109","journal-title":"Aliment Pharmacol Ther"},{"key":"950_CR7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00315472","volume":"44","author":"B Klemetsdal","year":"1993","unstructured":"Klemetsdal B, Straume B, Wist E, Aarbakke J (1993) Identification of factors regulating thiopurine methyltransferase activity in a Norwegian population. Eur J Clin Pharmacol 44:147\u2013152","journal-title":"Eur J Clin Pharmacol"},{"key":"950_CR8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/BF00203784","volume":"49","author":"RA Lysaa","year":"1996","unstructured":"Lysaa RA, Giverhaug T, Wold HL, Aarbakke J (1996) Inhibition of human thiopurine methyltransferase by furosemide, bendroflumethiazide and trichlormethiazide. Eur J Clin Pharmacol 49:393\u2013396","journal-title":"Eur J Clin Pharmacol"},{"key":"950_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF00194412","volume":"46","author":"R Capdeville","year":"1994","unstructured":"Capdeville R, Mousson B, Bax G, Bertrand Y, Philippe N (1994) Interactions between 6-mercaptopurine therapy and thiopurine methyltransferase (TPMT) activity. Eur J Clin Pharmacol 46:385\u2013386","journal-title":"Eur J Clin Pharmacol"},{"key":"950_CR10","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0140-6736(90)91745-V","volume":"336","author":"L Lennard","year":"1990","unstructured":"Lennard L, Lilleyman JS, van Loon J, Weinshilboum RM (1990) Genetic variation in response to 6-mercaptopurine for childhood acute lymphoblastic leukemia. Lancet 336:225\u2013229","journal-title":"Lancet"},{"key":"950_CR11","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","volume":"85","author":"HL McLeod","year":"1995","unstructured":"McLeod HL, Relling MV, Liu Qing, Pui CH, Evans WE (1995) Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukaemia. Blood 85:1897\u20131902","journal-title":"Blood"},{"key":"950_CR12","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1081\/NCN-200027643","volume":"23","author":"M Arenas","year":"2004","unstructured":"Arenas M, Duley JA, Ansari A, Schobowale-Bakre EA, Fairbanks L, Soon SY, Sanderson J, Marinaki AM (2004) Genetic determinants of the pre- and post-azathioprine therapy thiopurine methyltransferase activity phenotype. Nucleosides Nucleotides Nucleic Acids 23:1403\u20131405","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"950_CR13","first-page":"734","volume":"218","author":"LC Woodson","year":"1981","unstructured":"Woodson LC, Maus TP, Reiter C, Weinshilboum RM (1981) Rat thiopurine methyltransferase: regulation by testosterone. J Pharmacol Experim Ther 218:734\u2013738","journal-title":"J Pharmacol Experim Ther"},{"key":"950_CR14","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s002280050457","volume":"54","author":"T Kr\u00f6plin","year":"1998","unstructured":"Kr\u00f6plin T, Weyer N, Gutsche S, Iven H (1998) Thiopurine S-methyltransferase activity in human erythrocytes: a new HPLC method using 6-thioguanine as substrate. Eur J Clin Pharmacol 54:265\u2013271","journal-title":"Eur J Clin Pharmacol"},{"key":"950_CR15","first-page":"651","volume":"32","author":"RM Weinshilboum","year":"1980","unstructured":"Weinshilboum RM, Sladek SL (1980) Mercaptopurine pharmacogenetics: monogenic inheritance of erythrocyte thiopurine methyltransferase activity. Am J Hum Genet 32:651\u2013662","journal-title":"Am J Hum Genet"},{"key":"950_CR16","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00007691-199706000-00013","volume":"19","author":"S Bergan","year":"1997","unstructured":"Bergan S, Rugstad HE, Klemetsdal B, Giverhaug T, Bentdal O, Sodal G, Hartmann A, Aarbakke J, Stokke O (1997) Possibilities for therapeutic drug monitoring or azathioprine: 6-thioguanine nucleotide concentrations and thiopurine methyltransferase activity in red blood cells. Ther Drug Monit 19:318\u2013326","journal-title":"Ther Drug Monit"},{"key":"950_CR17","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2165\/00003088-199222040-00006","volume":"22","author":"JJM Van Meyel","year":"1992","unstructured":"Van Meyel JJM, Gerlag PGG, Smits P, Russel FGM, Tan Y, Van Ginneken CAM, Gribnau FWJ (1992) Absorption of high dose furosemide (frusemide) in congestive heart failure. Clin Pharmacokinet 22:308\u2013318","journal-title":"Clin Pharmacokinet"},{"key":"950_CR18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2165\/00003088-199018050-00004","volume":"18","author":"LLB Ponto","year":"1990","unstructured":"Ponto LLB, Schoenwald RD (1990) Furosemide (frusemide). A pharmacokinetic\/pharmacodynamic review (part I). Clin Pharmacokinet 18:381\u2013408","journal-title":"Clin Pharmacokinet"},{"key":"950_CR19","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/BF00196113","volume":"46","author":"G Ruf","year":"1994","unstructured":"Ruf G, Gera S, Luus HG, Trenk D, de la Rey N, Loffler K, Schulz W, J\u00e4hnchen E (1994) Pharmacokinetics and pharmacodynamics of ramipril and piretanide administrated alone and in combination. Eur J Clin Pharmacol 46:545\u2013550","journal-title":"Eur J Clin Pharmacol"},{"key":"950_CR20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2125.1983.tb01509.x","volume":"15","author":"KJ Berg","year":"1983","unstructured":"Berg KJ, Walstad RA, Bergh K (1983) The pharmacokinetics and diuretic effects of piretanide in chronic renal insufficiency. Br J Clin Pharmacol 15:347\u2013353","journal-title":"Br J Clin Pharmacol"},{"key":"950_CR21","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2165\/00003088-198713040-00003","volume":"13","author":"B Beermann","year":"1987","unstructured":"Beermann B, Grind M (1987) Clinical pharmacokinetics of some newer diuretics. Clin Pharmacokinet 13:254\u2013266","journal-title":"Clin Pharmacokinet"},{"key":"950_CR22","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/00007890-199205000-00016","volume":"53","author":"PR Chocair","year":"1992","unstructured":"Chocair PR, Duley JA, Simmonds HA, Cameron JS (1992) The importance of thiopurine methyltransferase activity for the use of azathioprine in transplant recipients. Transplantation 53:1051\u20131056","journal-title":"Transplantation"},{"key":"950_CR23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00007890-198004000-00006","volume":"29","author":"SN Lin","year":"1980","unstructured":"Lin SN, Jessup K, Floyd M, Wang TP, van Buren CT, Caprioli RM, Kahan BD (1980) Quantitation of plasma azathioprine and 6-mercaptopurine levels in renal transplant patients. Transplantation 29:290\u2013294","journal-title":"Transplantation"},{"key":"950_CR24","first-page":"3654","volume-title":"Azathioprine AHFS drug information","author":"GK McEvoy","year":"2005","unstructured":"McEvoy GK (ed) (2005) Azathioprine. AHFS drug information. American Society of Health System Pharmacists Inc, Bethesda, MD, pp 3654\u20133656"},{"key":"950_CR25","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1749-6632.1954.tb40020.x","volume":"60","author":"GB Elion","year":"1954","unstructured":"Elion GB, Bieber S, Hitchings GH (1954) The fate of 6-mercaptopurine in mice. Ann NY Acad Sci 60:297\u2013303","journal-title":"Ann NY Acad Sci"},{"key":"950_CR26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2165\/00003088-198916030-00002","volume":"16","author":"R Venkataramanan","year":"1989","unstructured":"Venkataramanan R, Habucky K, Burckart GJ, Ptachcinski RJ (1989) Clinical pharmacokinetics in organ transplant patients. Clin Pharmacokinet 16:134\u2013161","journal-title":"Clin Pharmacokinet"},{"key":"950_CR27","first-page":"171","volume":"Suppl","author":"A Vermeulen","year":"1976","unstructured":"Vermeulen A (1976) Plasma levels and secretion rate of steroids with anabolic activity in man. Environ Qual Saf Suppl:171\u2013180","journal-title":"Environ Qual Saf"},{"key":"950_CR28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/jc.2003-030680","volume":"89","author":"KK Miller","year":"2004","unstructured":"Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A (2004) Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525\u2013533","journal-title":"J Clin Endocrinol Metab"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0950-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-005-0950-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-005-0950-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T15:57:23Z","timestamp":1586275043000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-005-0950-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6,11]]},"references-count":28,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["950"],"URL":"https:\/\/doi.org\/10.1007\/s00228-005-0950-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,6,11]]}}}